Australia markets closed

Genetron Holdings Limited (GTH)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
3.9800-0.2400 (-5.69%)
At close: 04:00PM EST
3.9800 0.00 (0.00%)
After hours: 04:00PM EST
Full screen
Trade prices are not sourced from all markets
Previous close4.2200
Open4.2200
Bid0.0000 x 800
Ask0.0000 x 1000
Day's range3.9350 - 4.3300
52-week range3.9350 - 31.5400
Volume504,305
Avg. volume314,375
Market cap353.709M
Beta (5Y monthly)N/A
PE ratio (TTM)N/A
EPS (TTM)-0.6980
Earnings date23 Mar 2022 - 28 Mar 2022
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est14.53
  • GlobeNewswire

    Genetron Health Reiterates Full Year 2021 Revenue Guidance

    BEIJING, Jan. 10, 2022 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (“Genetron Health” or the “Company”, Nasdaq: GTH), a leading precision oncology platform company in China that specializes in offering molecular profiling tests, early cancer screening products and companion diagnostics development, today reiterated its full year 2021 revenue guidance. The Company expects full year 2021 revenue to be around RMB 530 million, representing approximately 25% growth over the Company’s full year 2020

  • GlobeNewswire

    Genetron Health’s Social Contribution Campaign to Make Precision Medicine More Accessible

    BEIJING, Dec. 13, 2021 (GLOBE NEWSWIRE) -- (“Genetron Health” or the “Company”, NASDAQ: GTH), a leading precision oncology platform company in China that specializes in offering molecular profiling tests, early cancer screening products and companion diagnostics development, announced the launch of the “Lung Loves New Life” genetic testing campaign, in collaboration with the China Primary Health Care Foundation. As the sole corporate donor, Genetron Health will provide free genetic testing servi

  • Motley Fool

    Why Shares of Genetron Holdings Are Up More than 9.3% on Tuesday

    Genetron Holdings (NASDAQ: GTH), a Chinese oncology testing company, briefly climbed to a high of $11.11 a share on Tuesday morning, up more than 9.3% over its closing price of $9.60 a share on Monday. Genetron reported its third-quarter earnings before the market opened on Tuesday. It also said that its gross margins had grown from 62% to 69%.